Program

SESSION 1: STATE OF THE ART

Discussants: L. Catena, M. Fassan, F. Grillo, F. Panzuto, A. Trama

09:00-09:20 Disparities between survival data derived from epidemiological studies and clinical trials Faivre

09:20-09:40 Overview of circulating biomarkers in NETs Tiensuu Janson

09:40-10:00 Whole-genome landscape of pNETs A. Scarpa

10:00-10:20 New opportunities of molecular targeted therapies, and combined role with immunotherapy N. Fazio

10:20-10:40 Current treatment of G3 NENs Sorbye

10:40-11:00 Coffee break

Discussants: V. Ambrosini, G. Delconte, S. Massironi, F. Riccardi

11:00-11:20 New standards in endoscopy in gastric, duodenal, pancreatic and rectal NETs M. Mutignani

11:20-11:40 Effect of combined therapies for liver metastases: novel strategies V. Mazzaferro

11:40-12:00 Role of adjuvant and neoadjuvant therapies in NET surgery M. Falconi

12:00-12:20 Theranostics in NET: update and novel strategies Singh

Dedication: E. Bajetta, S. Artale

12:20-12:50 Award: Roberto Buzzoni

12:50-14:00 Lunch

Board coordinators and question makers: Fazio, J. Coppa

Participants: T. Cascella, A. Faggiano, M. Milione, S. Pusceddu, C. Sposito, A. Versari

Participants: R. Baldelli, M. Bongini, M. Maccauro, M. Milione, S. Partelli, N. Prinzi, F. Spada, C. Spreafico

16:00-16:30 Coffee break

Chairs: C. Carnaghi, D. Conte

16:30-16:45 Quality of life and chronicity in NET patients management F. Roila

16:45-17:00 Have we got specific indicators for the electronic patient report outcomes (EPROs)? Bhoori, J. Coppa

17:00-17:30 Patient’s perspective on quality of life in NET: voting session S. Bhoori, J. Coppa, M. Guglielmo

17:30-17:45 Take-home messages and closure